Research Analysis Reports Cystic Fibrosis | Page 2

Phone : 1-415-349-0054 Toll Free : 1-888-202-9519 Email : sales @ radiantinsights . com Web : http :// www . radiantinsights . com /
Scope
‣ To what extent is the CF market landscape expected to change with the introduction of new CFTR modulators ?
‣ What are the clinical characteristics of currently approved therapies for CF , in terms of specific safety and efficacy parameters ?
‣ What are the key unmet needs in this indication , and which clinical safety and efficacy parameters are the most closely linked to them ?
‣ How will current late-stage CFTR modulators affect the market for symptomatic therapies , and are they able to yield comparable clinical efficacy results to Kalydeco ?
‣ How will the influx of tobramycin generics affect the competitive landscape ?
Reasons To Buy
‣ Understand the current clinical landscape by considering the treatment options available for each patient segment .
‣ Visually compare the currently approved treatments available at each line of therapy , based on the most important efficacy and safety parameters tested in clinical trials .
‣ Assess the current late-stage pipeline , in terms of the likely positioning of each product and the implications for the clinical landscape at each line of therapy .
‣ Understand the relative strengths and weaknesses of the studies used to gather these data .
‣ Build up a nuanced understanding of the clinical benchmarks set by these products , and consider how the current late-stage pipeline will affect these benchmarks .
‣ Assess your own pipeline programs in light of these benchmarks in order to optimally position them and maximize uptake by clinicians .
Browse Other Reports of This Category at : http :// www . radiantinsights . com / catalog / pharmaceuticals-and-healthcare
Table of Contents :
1 . Report Guidance 3 2 . Marketed Products 4 3 . Antimicrobeals 4 4 . Mucolytic Agents 5 5 . Pancreatic Enzymes 6 6 . CFTR modulators 6 7 . Pipeline Products 8 8 . Changes to Antimicrobeals , 2016-2022 8 9 . Changes to Mucolytic Agents , 2016-2022 8 10 . Changes to Pancretic Enzymes , 2016-2022 8 11 . Changes to CFTR Modulators , 2016-2022 9
https
:// www . facebook . com / RadiantInsights
https :// www . linkedin . com / company / radiant-insights https :// twitter . com / radiantinsights
https :// plus . google . com /+ Radiantinsights